This page provides data points and curated searches from OMH’s Knowledge Center library catalog related to HIV and AIDS within minority and tribal populations in the United States and its territories. The number of catalog records for each topic reflect the search results at the time of this page’s latest update.
Human immunodeficiency virus (HIV), is a virus that attacks the body’s immune system. If it is not treated, HIV can lead to acquired immunodeficiency syndrome (AIDS), which is the most advanced stage of HIV infection. Most people get HIV through anal or vaginal sex or by sharing equipment used to inject drugs. The only way to know for sure whether you have HIV is to get tested.
Treatment as Prevention (TasP) refers to taking HIV medicine to prevent the sexual transmission of HIV. PrEP, or pre-exposure prophylaxis, is taken to prevent getting HIV from sex or injection drug use. PEP, or post-exposure prophylaxis, is taken very soon after a possible exposure to HIV to prevent the virus from taking hold in your body.
HIV treatment can slow or stop the virus from progressing as well as prevent transmitting HIV to others. When HIV is not treated, it usually develops in three stages. The first stage is acute HIV infection, which happens soon after someone gets the virus. The second stage is chronic HIV infection, when the virus is still active, but symptoms may be mild or not noticeable. The third stage is AIDS. People with AIDS have severely weakened immune systems and are more likely to get serious illnesses. Without treatment, people with AIDS usually live about three years. Because of advances in treatment, far fewer people today develop AIDS.
American Indian/Alaska Native
In 2023, AI/AN people were 28% less likely than the U.S. population overall to be diagnosed with HIV. In 2023, AI/AN teens and young adults ages 13–24 were 56% less likely than others their age nationwide to have HIV. In 2023, AI/AN children under age 12 were diagnosed with HIV three times as often as children nationwide. In 2023, AI/AN people ages 13 and older were 64% less likely than the U.S. population to have AIDS. In 2023, AI/AN people ages 13 and older who had AIDS were 49% less likely to die than people with AIDS nationwide. In 2018, AI/AN adults were 7% more likely than U.S. adults overall to have ever been tested for HIV.
For additional data on HIV/AIDS and American Indians/Alaska Natives, please visit our Population Profiles.
Asian American
In 2023, Asian Americans were 66% less likely than the U.S. population overall to be diagnosed with HIV. In 2023, Asian American teens and young adults ages 13–24 were 74% less likely than others their age nationwide to have HIV. In 2023, Asian American children under age 12 were diagnosed with HIV at the same rate as children nationwide. In 2023, Asian Americans ages 13 and older were 78% less likely than the U.S. population to have AIDS. In 2023, Asian Americans ages 13 and older who had AIDS were 92% less likely to die than people with AIDS nationwide. In 2018, Asian American adults were 10% less likely than U.S. adults overall to have ever been tested for HIV.
For additional data on HIV/AIDS and Asian Americans, please visit our Population Profiles.
Black/African American
In 2023, Black/African Americans were more than three times as likely as the U.S. population overall to be diagnosed with HIV. In 2023, Black/African American teens and young adults ages 13–24 were nearly four times as likely to have HIV as others their age nationwide. In 2023, Black/African American children under age 12 were diagnosed with HIV five times as often as children nationwide. In 2023, Black/African Americans ages 13 and older were more than three times as likely as the U.S. population to have AIDS. In 2023, Black/African Americans ages 13 and older who had AIDS were more than three times as likely to die as people with AIDS nationwide. In 2018, Black/African American adults were 44% more likely than U.S. adults overall to have ever been tested for HIV.
For additional data on HIV/AIDS and Black or African Americans, please visit our Population Profiles.
Hispanic/Latino
In 2023, Hispanic/Latino Americans were 72% more likely than the U.S. population overall to be diagnosed with HIV. In 2023, Hispanic/Latino teens and young adults ages 13–24 were 14% more likely than others their age nationwide to have HIV. In 2023, Hispanic/Latino children under age 12 were diagnosed with HIV at the same rate as children nationwide. In 2023, Hispanic/Latino Americans ages 13 and older were 38% more likely than the U.S. population to have AIDS. In 2023, Hispanic/Latino Americans ages 13 and older who had AIDS were 4% more likely to die than people with AIDS nationwide. In 2018, Hispanic/Latino adults were 4% more likely than U.S. adults overall to have ever been tested for HIV.
For additional data on HIV/AIDS and Hispanic/Latino Americans, please visit our Population Profiles.
Native Hawaiian/Pacific Islander
In 2023, NHPI people were 28% less likely than the U.S. population overall to be diagnosed with HIV. In 2023, NHPI teens and young adults ages 13–24 were 25% less likely than others their age nationwide to have HIV. In 2023, no NHPI children under age 12 were diagnosed with HIV. In 2023, NHPI people ages 13 and older were 92% less likely than the U.S. population to have AIDS. In 2023, NHPI people ages 13 and older who had AIDS were 62% less likely to die than people with AIDS nationwide. In 2018, NHPI adults were about as likely as U.S. adults overall to have ever been tested for HIV.
For additional data on HIV/AIDS and Native Hawaiians/Other Pacific Islanders, please visit our Population Profiles.
Date Last Reviewed: February 2026